Functional calcitonin gene-related peptide type 1 and adrenomedullin receptors in human trigeminal ganglia, brain vessels, and cerebromicrovascular or astroglial cells in culture

被引:38
作者
Moreno, MJ
Cohen, Z
Stanimirovic, DB
Hamel, E
机构
[1] Montreal Neurol Inst, Dept Neurol & Neurosurg, Lab Cerebrovasc Res, Montreal, PQ H3A 2B4, Canada
[2] Natl Res Council Canada, Inst Biol Sci, Cellular Neurobiol Grp, Ottawa, ON K1A 0R6, Canada
关键词
smooth muscle cells; endothelial cells; astrocytes; trigeminal ganglia; migraine; stroke;
D O I
10.1097/00004647-199911000-00012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Calcitonin gene-related peptide (CGRP) and adrenomedullin (ADM) are potent dilators of human brain arteries, and they have been implicated in the neurogenic inflammation underlying migraine headache and in the evolution of stroke, respectively. However, little is known about the presynaptic and postsynaptic distribution of their respective receptors in the human cerebrovascular bed and trigeminovascular system. In the current study, the expression of mRNA for ADM and the two cloned human CGRP, receptors (identified here as A-CGRP, receptors [Aiyar et al., 1996] and K-CGRP, receptors) [Kapas and Clark. 1995] were evaluated in human brain vessels and trigeminal ganglia. Further, the ability of CGRP and ADM to activate adenylate cyclase in cerebromicrovascular and astroglial cell cultures was determined, and the receptors involved were characterized pharmacologically. Isolated human pial vessels, intracortical microvessels, and capillaries, as well as cultures of brain endothelial (EC), smooth muscle (SMC), and astroglial (AST) cells, all expressed mRNA for the two cloned CGRP, receptors; however, message for the K-CGRP, receptor was barely detectable in microvascular tissues and cells. In contrast, only isolated capillaries and cultured AST exhibited message for the ADM receptor. In human trigeminal ganglia, mRNA for ADM and the two CGRP, receptors was systematically present. The CGRP dose-dependently increased (up to 50-fold) cAMP formation in cell cultures, an effect significantly blocked by 0.1 to 10 mu mol/L of the CGRP, receptor antagonist CGRP(8-37). The ADM receptor agonist, ADM(13-52) (1 mu mol/L), similarly increased cAMP production in all cell types, and this response was virtually abolished by 1 mu moYL CGRP(8-37), LOW concentrations (1 to 10 mu mol/L) of the ADM receptor antagonist ADM(22-52) blocked the ADM(13-52)-induced cAMP formation in AST (26% nt 10 mu mol/L, P < 0.05), whereas they potentiated this response in brain EC and SMC (40% and 100%, P < 0.001, respectively). Even at a higher dose (50 mu mol/L), ADM22-52 inhibited the ADM(13-52) effect in vascular cells (45%) much less effectively than in AST (95%). These results indicate that both CGRP and ADM can affect human brain vessels through a CGRP, receptor, and they further suggest the presence of functional ADM receptors in human astroglial cells.
引用
收藏
页码:1270 / 1278
页数:9
相关论文
共 41 条
[1]   Expression of neuropeptide Y receptors mRNA and protein in human brain vessels and cerebromicrovascular cells in culture [J].
Abounader, R ;
Elhusseiny, A ;
Cohen, Z ;
Olivier, A ;
Stanimirovic, D ;
Quirion, R ;
Hamel, E .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1999, 19 (02) :155-163
[2]   A cDNA encoding the calcitonin gene-related peptide type 1 receptor [J].
Aiyar, N ;
Rand, K ;
Elshourbagy, NA ;
Zeng, ZZ ;
Adamou, JE ;
Bergsma, DJ ;
Li, Y .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (19) :11325-11329
[3]  
ALKAYED NJ, 1997, STROKE, V28, P1006
[4]   EFFECTS OF ADRENOMEDULLIN, CALCITONIN-GENE-RELATED PEPTIDE, AND AMYLIN ON CEREBRAL-CIRCULATION IN DOGS [J].
BASKAYA, MK ;
SUZUKI, Y ;
ANZAI, M ;
SEKI, Y ;
SAITO, K ;
TAKAYASU, M ;
SHIBUYA, M ;
SUGITA, K .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1995, 15 (05) :827-834
[5]   Adrenomedullin-(22-52) antagonizes vasodilator responses to CGRP but not adrenomedullin in the cat [J].
Champion, HC ;
Santiago, JA ;
Murphy, WA ;
Coy, DH ;
Kadowitz, PJ .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 1997, 272 (01) :R234-R242
[6]  
Durham PL, 1997, J NEUROSCI, V17, P9545
[7]   CALCITONIN GENE-RELATED PEPTIDE AND CEREBRAL BLOOD-VESSELS - DISTRIBUTION AND VASOMOTOR EFFECTS [J].
EDVINSSON, L ;
EKMAN, R ;
JANSEN, I ;
MCCULLOCH, J ;
UDDMAN, R .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1987, 7 (06) :720-728
[8]   Expression of calcitonin gene-related peptide(1) receptor mRNA in human trigeminal ganglia and cerebral arteries [J].
Edvinsson, L ;
Cantera, L ;
JansenOlesen, I ;
Uddman, R .
NEUROSCIENCE LETTERS, 1997, 229 (03) :209-211
[9]  
EDWARDS RM, 1991, J PHARMACOL EXP THER, V257, P1020
[10]   VASODILATORY ACTIONS OF CALCITONIN-GENE-RELATED PEPTIDE AND NITRIC-OXIDE IN PARENCHYMAL MICROVESSELS OF THE RAT HIPPOCAMPUS [J].
FERGUS, A ;
JIN, YC ;
THAI, QA ;
KASSELL, NF ;
LEE, KS .
BRAIN RESEARCH, 1995, 694 (1-2) :78-84